Biological therapy in Takayasu arteritis. Results from the REVAS registry

European Journal of Internal Medicine · Published 2026-07-01 · DOI 10.1016/j.ejim.2026.107111

Authors (8)

J Mestre-Torres, JL Callejas-Rubio, M Pérez-Conesa, B de Escalante-Yangüela, A Núñez-Conde, F Martínez-Valle, EM Fonseca-Aizpuru, R Solans-Laqué

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Mestre-Torres, J., Callejas-Rubio, J., Pérez-Conesa, M., et al. (2026). Biological therapy in Takayasu arteritis. Results from the REVAS registry. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2026.107111

Related articles

• Early vasopressin in septic shock: Which evidence should we trust? · European Journal of Internal Medicine · 2026 · Same journal
• Particle engineering, aerosol physics, and pulmonary deposition of single-inhaler triple ICS/LABA/LAMA therapies in obstructive airway diseases · European Journal of Internal Medicine · 2026 · Same journal
• Clarifying the lipid signal: non-HDL cholesterol, remnant cholesterol and metabolic risk in primary care · European Journal of Internal Medicine · 2026 · Same journal
• Left atrial enlargement without atrial fibrillation: a warning signal rather than a treatment target · European Journal of Internal Medicine · 2026 · Same journal
• Rethinking residual sex effects in frailty-adjusted ICU mortality · European Journal of Internal Medicine · 2026 · Same journal
• Cardiac rehabilitation referral and access by country income class: Comparisons from the International Council of Cardiovascular Prevention and Rehabilitation’s 2025 Global Audit Update · European Journal of Internal Medicine · 2026 · Same journal
• Beyond comorbidities: Age as an independent predictor of survival in pulmonary arterial hypertension · European Journal of Internal Medicine · 2026 · Same journal
• Clinical and prognostic significance of urinary albumin-to-creatinine ratio in heart failure: insights from the RICA-2 registry · European Journal of Internal Medicine · 2026 · Same journal
• Impact of ECOG performance status on cancer-associated thrombosis treated with DOACs: Data from a multicenter cohort study · European Journal of Internal Medicine · 2026 · Same journal
• Lower incidence of venous thromboembolism in hospital-at-home patients: Do unequal detection opportunities and between-group non-equivalence affect the interpretation of the findings? Author's Reply · European Journal of Internal Medicine · 2026 · Same journal